{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:30:59Z","timestamp":1787315459074,"version":"build-2736575974"},"reference-count":23,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1185\/030079906x80404","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T16:48:40Z","timestamp":1137602920000},"page":"375-384","source":"Crossref","is-referenced-by-count":218,"title":["Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13\u2010week, randomized trial"],"prefix":"10.1185","volume":"22","author":[{"given":"Robert","family":"van Seventer","sequence":"first","affiliation":[{"name":"Amphia Ziekenhuis, Department of Anaesthesiology, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary A.","family":"Feister","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James P.","family":"Young","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Stoker","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Sandwich, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Versavel","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Rigaudy","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Fresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2006,1,17]]},"reference":[{"key":"CIT0001","first-page":"959","volume":"63","author":"Dubinsky RM","year":"2004","journal-title":"El-Chami Z, et al. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.1995.tb02723.x"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03122-3"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.1166"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.33"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.9.1427"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.6.671"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350716"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00244-9"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1837"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.10.5768"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00172-1"},{"key":"CIT0015","first-page":"107","volume":"280","author":"Dooley DJ","year":"2000","journal-title":"Inhibition of K+\u2013evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(98)00108-9"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.05.001"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000145767.36287.A1"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.12.007"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055433.55136.55"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.01.001"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.02.032"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003251119"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00349-9"},{"key":"CIT0029","first-page":"215","volume":"94","author":"Rice ASC","year":"2001","journal-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X80404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T11:59:09Z","timestamp":1536580749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X80404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,17]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,12,9]]},"published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1185\/030079906X80404"],"URL":"https:\/\/doi.org\/10.1185\/030079906x80404","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,17]]}}}